FSSAI issues notices to Nestlé India, Zydus Wellness over product claims

The Food Safety and Standards Authority of India (FSSAI) has issued formal notices to Zydus Wellness and Nestlé India, asking them to provide scientific proof for specific claims made on their infant nutrition and health drink products. This regulatory action follows a review of marketing materials for items like Complan and Lactogen Pro 1.

For investors, this development highlights the increasing scrutiny the food and beverage sector faces regarding advertising standards. While the notices do not yet indicate a violation, they introduce uncertainty regarding potential future compliance costs or product label changes. The company has stated its claims are factual, but the need to provide evidence creates short-term volatility for the stock.

Investors should watch for the company's official response to the regulator and any subsequent updates on the timeline for resolving these queries. A delay in providing the required scientific data could lead to product restrictions, whereas a swift, compliant resolution would likely neutralize the immediate market concern.